Updates on mPAC: Is There a Target Group for Oligometastatic Disease? Biomarker Data, ctDNA, Surgery and Survival Data, Locoregional Treatment in mPDAC, QoL
By
CECOG Academy
FEATURING
Thomas Seufferlein
By
CECOG Academy
FEATURING
Thomas Seufferlein
Comments 0
Login to view comments.
Click here to Login
